HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of a novel recycling sequence in the C-tail of FPR2/ALX receptor: association with cell protection from apoptosis.

Abstract
Formyl-peptide receptor type 2 (FPR2; also called ALX because it is the receptor for lipoxin A4) sustains a variety of biological responses relevant to the development and control of inflammation, yet the cellular regulation of this G-protein-coupled receptor remains unexplored. Here we report that, in response to peptide agonist activation, FPR2/ALX undergoes β-arrestin-mediated endocytosis followed by rapid recycling to the plasma membrane. We identify a transplantable recycling sequence that is both necessary and sufficient for efficient receptor recycling. Furthermore, removal of this C-terminal recycling sequence alters the endocytic fate of FPR2/ALX and evokes pro-apoptotic effects in response to agonist activation. This study demonstrates the importance of endocytic recycling in the anti-apoptotic properties of FPR2/ALX and identifies the molecular determinant required for modulation of this process fundamental for the control of inflammation.
AuthorsDawn Thompson, Simon McArthur, James N Hislop, Roderick J Flower, Mauro Perretti
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 289 Issue 52 Pg. 36166-78 (Dec 26 2014) ISSN: 1083-351X [Electronic] United States
PMID25326384 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Chemical References
  • Arrestins
  • FPR2 protein, human
  • Receptors, Formyl Peptide
  • Receptors, Lipoxin
  • beta-Arrestins
Topics
  • Amino Acid Sequence
  • Apoptosis
  • Arrestins (metabolism)
  • HEK293 Cells
  • Humans
  • MAP Kinase Signaling System
  • Molecular Sequence Data
  • Protein Binding
  • Protein Structure, Tertiary
  • Protein Transport
  • Receptors, Formyl Peptide (chemistry, metabolism)
  • Receptors, Lipoxin (chemistry, metabolism)
  • beta-Arrestins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: